Jove
Visualize
Contact Us

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

461
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
461
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

178
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
178

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gene expression and metadata based identification of key genes for lung cancer, COPD, and IPF using machine learning and statistical models.

PloS one·2026
Same author

Deep Learning-Based Eye-Writing Recognition with Improved Preprocessing and Data Augmentation Techniques.

Sensors (Basel, Switzerland)·2025
Same author

Bangla Speech Emotion Recognition Using Deep Learning-Based Ensemble Learning and Feature Fusion.

Journal of imaging·2025
Same author

A Comprehensive Methodological Survey of Human Activity Recognition Across Diverse Data Modalities.

Sensors (Basel, Switzerland)·2025
Same author

Identification of potential biomarkers for lung cancer using integrated bioinformatics and machine learning approaches.

PloS one·2025
Same author

Stacked CNN-based multichannel attention networks for Alzheimer disease detection.

Scientific reports·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 23, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K

Residual-Based Multi-Stage Deep Learning Framework for Computer-Aided Alzheimer's Disease Detection.

Najmul Hassan1, Abu Saleh Musa Miah1, Jungpil Shin1

  • 1School of Computer Science and Engineering, The University of Aizu, Aizuwakamatsu 965-8580, Japan.

Journal of Imaging
|June 26, 2024
PubMed
Summary

A new multi-stage deep neural network accurately detects Alzheimer's Disease (AD). This advanced system shows high accuracy, offering a significant improvement for early AD detection and analysis in medical imaging.

Keywords:
Alzheimer’s diseaseCNNRandom Forestmachine learningresidual network

More Related Videos

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

40.2K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K

Related Experiment Videos

Last Updated: Jun 23, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K
Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

40.2K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K

Area of Science:

  • Neurology
  • Medical Imaging
  • Artificial Intelligence

Background:

  • Alzheimer's Disease (AD) is a leading cause of dementia globally, affecting over 50% of elderly Japanese.
  • Current AD detection methods struggle with the complexity of deep learning models.
  • There is a critical need for automated and accurate AD detection systems.

Purpose of the Study:

  • To introduce a novel multi-stage deep neural network for enhanced Alzheimer's Disease detection.
  • To address the limitations of existing hierarchical convolutional neural networks (CNNs) in AD analysis.
  • To improve the accuracy and efficiency of automated AD detection systems.

Main Methods:

  • A five-stage deep neural network architecture utilizing residual functions for feature enhancement.
  • Integration of a deep learning-based feature selection module with batch normalization, dropout, and fully connected layers to prevent overfitting.
  • Classification using machine learning algorithms: Support Vector Machines (SVM), Random Forest (RF), and SoftMax.

Main Results:

  • The proposed model achieved high accuracy rates: 99.47% on ADNI1, 99.10% on MIRAID, and 99.70% on OASIS Kaggle datasets.
  • The system demonstrated superior performance compared to existing methods in binary classification tasks.
  • The multi-stage architecture effectively enhanced feature extraction and model depth.

Conclusions:

  • The novel multi-stage deep neural network offers a significant advancement in Alzheimer's Disease analysis.
  • The model's high accuracy suggests its potential for reliable automated AD detection.
  • This approach paves the way for more effective early diagnosis and management of Alzheimer's Disease.